Germany Expands Medical Cannabis Production Capacity at Leuna Facility

Aurora Cannabis has completed the expansion of its Leuna facility in Germany, one of only a few authorized centers in the country for cultivating medical cannabis. This expansion increases Germany's domestic production capacity for pharmaceutical-grade cannabis, supporting the country's medical cannabis program that began in 2017. The Leuna facility represents a significant investment in standardized, regulated cannabis cultivation for patients requiring medical cannabis treatments. This development strengthens Germany's position as a leader in European medical cannabis production and helps ensure reliable supply for patients with approved therapeutic indications.